2011 BPSA International Single-Use Summit (ISUS) Recap
July 27-29, 2011
The Four Seasons Hotel
Washington, DC
Contact:
BPSA
Jeanette McCool
mccoolj@socma.com
2011 Summit Recap
Nearly 100 registrants from the United States, Europe and Asia attended BPSA’s inaugural International Single-Use Summit (ISUS), July 27-29, 2011, in Washington, DC. Suppliers and users of single-use technology attended this business-focused Summit to hear presentations on the critical innovations and market drivers in the single-use manufacturing industry. The Summit also leveraged its Washington, DC venue by featuring sessions on the current legislative and regulatory initiatives affecting the biopharmaceutical industry, perspectives from Capitol Hill experts on prospects for further health-care reform amendments, and future market insights into biotechnology from leading market analysts. The Summit included several networking sessions designed to allow attendees to share their specific thoughts, ideas and concerns on the advancement of and challenges to the adoption of single-use technologies.
In addition to the business sessions, the group enjoyed a networking dinner cruise on the Potomac to enjoy the sights and sounds of Washington, DC by night.
BPSA would like to thank our Summit Sponsors:
ThermoFisher Scientific ATMI Millipore Pall Life Sciences Renolit Bosch Packaging Dow Corning Arkema, Inc. Bio-Process International Value Plastics, Inc.Speaker Presentations Thursday, July 28, 2011
- The Bio-Pharma Supply Chain in 2020: A Critical Lever for Value Creation
Wynn Bailey, Partner, Pricewaterhouse Coopers - Drug Manufacturing in a New Era of Safety
Claudia Lewis-Eng, Partner, Venable, LLC - Global Regulatory Scheme and the Adoption of Single-Use Technologies
David Doleski, Consumer Safety Officer, Division of Manufacturing and Product Quality, U.S. Food and Drug Administration - Universal Acceptance and Adoption of Disposable Processing Systems
Sarfaraz Niazi, Ph.D., Executive Chairman, Therapeutic Proteins, Inc., and President, Pharmaceutical Scientist Inc. - Personalized Medicines
Michael Ramsay, M.D., President, Baylor University Research Institute - Monoclonal Antibodies and Single-Use Technologies
Brad Wolk, Biopharmaceutical Industry Consultant, Wolk Engineering - Single-Use Technologies for Stem Cell Therapies
Eric Halioua, Chief Executive Officer, Promethera Biosciences, Belgium - Demands of Biomanufacturing toward Countermeasure or Pandemic Response and Potential Links to Disposable (Single-Use) Biomanufacturing Systems
Michael P. Angelastro, Project Officer, Biomedical Advanced Research & Development Authority, U.S. Department of Health and Human Services - The Implementation of Single-Use Technologies in China and the Future of Chinese Biomanufacturing
Lei Sun, Ph.D., President, Manufacture, AutekBio, Inc., Beijing, China
Speaker Presentations Friday, July 29, 2011
- Qualification/Validation/Best Practices for SUTs (The BPSA Guides)
Jerold Martin, Sr. V.P., Global Scientific Affairs, Pall Life Sciences - Economics of Single-Use Technologies
Todd Kapp, Business Development Manager, American RENOLIT Corporation, LA - Shared Single-Use Disposables Document Directory
Ken Baker, CEO, New Age Industries/Advantapure - Regulation and Risk Mitigation
David Radspinner, Director, Global Sales, Thermo Fisher Scientific, Inc. - End-of-Life and Disposal Issues and Challenges
John Boehm, Bioprocessing Business Unit Manager, Colder Products Company and
Mani Krishnan, Director, Single-use Processing Systems, EMD Millipore - The Future of Single-Use Technologies
Eric Langer, Managing Partner, BioPlan Associates, Inc. - Creating Ready to Supply Facilities
Steve Attig, Associate Sr. Process Engineer, CRB Consulting Engineers
